CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that revenues for the first quarter of fiscal 2012 increased 18% to $133.7 million, compared to revenues in the first quarter of last year of $113.2 million. Net income increased 70% to $6.6 million for the quarter, compared to $3.9 million in the prior year. Diluted earnings per share grew 61% to $0.29, compared to $0.18 in the prior year. Backlog at the end of the first quarter was approximately $24 million, as compared to $30 million at the end of Q4 2011 and $13 million at the end of Q1 2011.
